Clinical Development Operation Lead

**THE POSITION**:
We at Boehringer Ingelheim Medicine share one vision: to turn patient-focused innovations into life-changing treatments. We focus on driving medical innovation, combining scientific and patient insights to develop and deliver safe and effective solutions. By concentrating on first-in-class innovations, we aim to set new standards for patient care now and for years to come.

We build on the strongest of all our assets: Our people. We are an agile team with diverse skills, always striving for excellence. We embrace new technologies and trends, make use of broad data and leading analytics. Our professional ethos reflects our personal values. Above all, we are united by our passion for improving healthcare and the enduring commitment to delivering valuable solutions that transform lives today, tomorrow and beyond.

Clinical Development Operations Lead (CDOL) for is a senior leadership role within Clinical Development and Operations (CD&O) in Medicine.

We have several positions to fill worldwide.

The CDOL is functionally part of the asset evidence team. On behalf of CD&O, CDOL is accountable for operational strategy, planning, oversight and delivery of clinical programs within assigned indication or given asset with focus on speed, value and quality.

This position can be filled in Ingelheim or Biberach.

***Tasks & responsibilities**:
- As a senior leader of clinical delivery for assigned indication/asset, you are accountable for operational execution strategy and input into the Asset Evidence Plan.- You provide strategic and operational input into the Trial Design Outlines.- You drive strategic and operational clinical program execution excellence, planning, oversight and delivery of clinical programs/trials within assigned indication or given asset with focus on speed and value.- You develop and implement the Execution Excellence Plan as a part of the Asset Evidence Plan for given asset(s)- You contribute to digital innovation and use of novel trial designs, utilizing data, technology and input from external stakeholders (patient groups and potential investigators) to determine realistic development timelines, identify feasibility issues, roadblocks, supplier needs, external committees and expert mapping.- You closely collaborate with cross-functional teams in Medicine, TA and TMCP in creating processes or standards for improving execution efficiency, quality and value.

***Requirements**:
- PhD, MD or equivalent.- Long-term academic, clinical or industry experience in one of the following therapeutic areas (Inflammation, Oncology, Cardio Metabolism or CNS/Psychiatry)- Extensive experience across all stages of clinical drug development- Proven track record on overseeing and running global clinical programs- Leadership skills to influence and create teams with can-do-attitude- Good understanding of Health Authority regulations in key markets, Boehringer Ingelheim Code of Conduct, Corporate Medicine Standard Operating Procedures, Main Industry Associations Codes- Ability to effectively set direction, innovate, and communicate in a global ecosystem with a very diverse set of internal and external stakeholders- Proven ability to build strong relationships with internal and external traditional and non-traditional stakeholders as well as excellent interpersonal, active listening, and influencing skills. This includes investigator expert network, Contract Research Organizations (CRO), patient organizations and professional societies- Very pronounced strategic mindset and excellent communications and negotiation skills as well as the proven ability to build internal relationship and exert influence in a matrix and virtual environment and external relationship with thought leaders, industry bodies etc.- Curiosity, innovative thinking including the ability and a strong desire to know or learn something as well as inquisitiveness- Fluency in English, both written and spoken

***READY TO CONTACT US?**:
Please contact our HR Direct Team, Tel: +49 (0) 6132 77-3330.